Emergent Biosolutions Inc (EBS)
$6.81 -5.68% Close Oct 30, 2026 Live
Emergent Biosolutions stock today
Emergent Biosolutions closed at $6.81 on October 30, 2026, down 5.68% on the day. Over the past year it returned -47.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $351 million.
$5.00$10.00
NovJan 2026MarMayJulSep
| Period | EBS | S&P 500 (SPY) |
|---|---|---|
| 1 month | +3.2% | -0.9% |
| 3 months | -6.2% | +2.1% |
| Year to date | -44.9% | +11.7% |
| 1 year | -47.0% | +12.4% |
| 3 years | +235.5% | +88.5% |
| 5 years | -85.7% | +76.0% |
Key statistics
- Market value
- $351M
- Forward P/E
- 9.7
- Price / sales
- 0.5
- 52-week range
- $4.45 to $13.90
- Next report
- Nov 2, 2026
About Emergent Biosolutions
Manufactures vaccines and specialty pharmaceuticals for infectious diseases and emergencies.
Sector: Health Care
More on Emergent Biosolutions
- Financials: revenue, earnings and segmentsRevenue -29% in the year to Dec 2025
- Valuation: P/E history and peers
- Returns: what $1,000 became$1,000 ten years ago is $253.16 today
No forecast, no recommendation. This page describes Emergent Biosolutions Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.